Pharma & Healthcare
Global Pirfenidone Tablets Market Research Report 2026
- Feb 24, 26
- ID: 721040
- Pages: 115
- Figures: 114
- Views: 1
This report delivers a comprehensive overview of the global Pirfenidone Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pirfenidone Tablets. The Pirfenidone Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pirfenidone Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pirfenidone Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Accord Healthcare
Amneal Pharmaceuticals
Apotex
Sandoz
Teva
ScieGen Pharmaceuticals
Kawin
Segment by Type
200mg per Tablet
267mg per Tablet
801mg per Tablet
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pirfenidone Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pirfenidone Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Pirfenidone Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pirfenidone Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Accord Healthcare
Amneal Pharmaceuticals
Apotex
Sandoz
Teva
ScieGen Pharmaceuticals
Kawin
Segment by Type
200mg per Tablet
267mg per Tablet
801mg per Tablet
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pirfenidone Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pirfenidone Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Pirfenidone Tablets Market Overview
1.1 Product Definition
1.2 Pirfenidone Tablets by Type
1.2.1 Global Pirfenidone Tablets Market Value by Type: 2025 vs 2032
1.2.2 200mg per Tablet
1.2.3 267mg per Tablet
1.2.4 801mg per Tablet
1.3 Pirfenidone Tablets by Application
1.3.1 Global Pirfenidone Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Pirfenidone Tablets Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Tablets Revenue 2021–2032
1.4.2 Global Pirfenidone Tablets Sales 2021–2032
1.4.3 Global Pirfenidone Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pirfenidone Tablets Market Competition by Manufacturers
2.1 Global Pirfenidone Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pirfenidone Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pirfenidone Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pirfenidone Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pirfenidone Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pirfenidone Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Pirfenidone Tablets, Date of Entry into the Industry
2.8 Global Pirfenidone Tablets Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pirfenidone Tablets Players Market Share by Revenue
2.8.3 Global Pirfenidone Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Tablets Market Scenario by Region
3.1 Global Pirfenidone Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pirfenidone Tablets Sales by Region: 2021–2032
3.2.1 Global Pirfenidone Tablets Sales by Region: 2021–2026
3.2.2 Global Pirfenidone Tablets Sales by Region: 2027–2032
3.3 Global Pirfenidone Tablets Revenue by Region: 2021–2032
3.3.1 Global Pirfenidone Tablets Revenue by Region: 2021–2026
3.3.2 Global Pirfenidone Tablets Revenue by Region: 2027–2032
3.4 North America Pirfenidone Tablets Market Facts & Figures by Country
3.4.1 North America Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pirfenidone Tablets Sales by Country (2021–2032)
3.4.3 North America Pirfenidone Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pirfenidone Tablets Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pirfenidone Tablets Sales by Country (2021–2032)
3.5.3 Europe Pirfenidone Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pirfenidone Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Pirfenidone Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pirfenidone Tablets Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pirfenidone Tablets Sales by Country (2021–2032)
3.7.3 Latin America Pirfenidone Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pirfenidone Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pirfenidone Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pirfenidone Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pirfenidone Tablets Sales by Type (2021–2032)
4.1.1 Global Pirfenidone Tablets Sales by Type (2021–2026)
4.1.2 Global Pirfenidone Tablets Sales by Type (2027–2032)
4.1.3 Global Pirfenidone Tablets Sales Market Share by Type (2021–2032)
4.2 Global Pirfenidone Tablets Revenue by Type (2021–2032)
4.2.1 Global Pirfenidone Tablets Revenue by Type (2021–2026)
4.2.2 Global Pirfenidone Tablets Revenue by Type (2027–2032)
4.2.3 Global Pirfenidone Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Pirfenidone Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pirfenidone Tablets Sales by Application (2021–2032)
5.1.1 Global Pirfenidone Tablets Sales by Application (2021–2026)
5.1.2 Global Pirfenidone Tablets Sales by Application (2027–2032)
5.1.3 Global Pirfenidone Tablets Sales Market Share by Application (2021–2032)
5.2 Global Pirfenidone Tablets Revenue by Application (2021–2032)
5.2.1 Global Pirfenidone Tablets Revenue by Application (2021–2026)
5.2.2 Global Pirfenidone Tablets Revenue by Application (2027–2032)
5.2.3 Global Pirfenidone Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Pirfenidone Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Pirfenidone Tablets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Accord Healthcare Pirfenidone Tablets Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Company Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex Pirfenidone Tablets Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sandoz Pirfenidone Tablets Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Pirfenidone Tablets Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 ScieGen Pharmaceuticals
6.7.1 ScieGen Pharmaceuticals Company Information
6.7.2 ScieGen Pharmaceuticals Description and Business Overview
6.7.3 ScieGen Pharmaceuticals Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio
6.7.5 ScieGen Pharmaceuticals Recent Developments/Updates
6.8 Kawin
6.8.1 Kawin Company Information
6.8.2 Kawin Description and Business Overview
6.8.3 Kawin Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Kawin Pirfenidone Tablets Product Portfolio
6.8.5 Kawin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Tablets Industry Chain Analysis
7.2 Pirfenidone Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Tablets Production Mode & Process Analysis
7.4 Pirfenidone Tablets Sales and Marketing
7.4.1 Pirfenidone Tablets Sales Channels
7.4.2 Pirfenidone Tablets Distributors
7.5 Pirfenidone Tablets Customer Analysis
8 Pirfenidone Tablets Market Dynamics
8.1 Pirfenidone Tablets Industry Trends
8.2 Pirfenidone Tablets Market Drivers
8.3 Pirfenidone Tablets Market Challenges
8.4 Pirfenidone Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pirfenidone Tablets by Type
1.2.1 Global Pirfenidone Tablets Market Value by Type: 2025 vs 2032
1.2.2 200mg per Tablet
1.2.3 267mg per Tablet
1.2.4 801mg per Tablet
1.3 Pirfenidone Tablets by Application
1.3.1 Global Pirfenidone Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Pirfenidone Tablets Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Tablets Revenue 2021–2032
1.4.2 Global Pirfenidone Tablets Sales 2021–2032
1.4.3 Global Pirfenidone Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pirfenidone Tablets Market Competition by Manufacturers
2.1 Global Pirfenidone Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pirfenidone Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pirfenidone Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pirfenidone Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pirfenidone Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pirfenidone Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Pirfenidone Tablets, Date of Entry into the Industry
2.8 Global Pirfenidone Tablets Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pirfenidone Tablets Players Market Share by Revenue
2.8.3 Global Pirfenidone Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Tablets Market Scenario by Region
3.1 Global Pirfenidone Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pirfenidone Tablets Sales by Region: 2021–2032
3.2.1 Global Pirfenidone Tablets Sales by Region: 2021–2026
3.2.2 Global Pirfenidone Tablets Sales by Region: 2027–2032
3.3 Global Pirfenidone Tablets Revenue by Region: 2021–2032
3.3.1 Global Pirfenidone Tablets Revenue by Region: 2021–2026
3.3.2 Global Pirfenidone Tablets Revenue by Region: 2027–2032
3.4 North America Pirfenidone Tablets Market Facts & Figures by Country
3.4.1 North America Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pirfenidone Tablets Sales by Country (2021–2032)
3.4.3 North America Pirfenidone Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pirfenidone Tablets Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pirfenidone Tablets Sales by Country (2021–2032)
3.5.3 Europe Pirfenidone Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pirfenidone Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Pirfenidone Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pirfenidone Tablets Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pirfenidone Tablets Sales by Country (2021–2032)
3.7.3 Latin America Pirfenidone Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pirfenidone Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pirfenidone Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pirfenidone Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pirfenidone Tablets Sales by Type (2021–2032)
4.1.1 Global Pirfenidone Tablets Sales by Type (2021–2026)
4.1.2 Global Pirfenidone Tablets Sales by Type (2027–2032)
4.1.3 Global Pirfenidone Tablets Sales Market Share by Type (2021–2032)
4.2 Global Pirfenidone Tablets Revenue by Type (2021–2032)
4.2.1 Global Pirfenidone Tablets Revenue by Type (2021–2026)
4.2.2 Global Pirfenidone Tablets Revenue by Type (2027–2032)
4.2.3 Global Pirfenidone Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Pirfenidone Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pirfenidone Tablets Sales by Application (2021–2032)
5.1.1 Global Pirfenidone Tablets Sales by Application (2021–2026)
5.1.2 Global Pirfenidone Tablets Sales by Application (2027–2032)
5.1.3 Global Pirfenidone Tablets Sales Market Share by Application (2021–2032)
5.2 Global Pirfenidone Tablets Revenue by Application (2021–2032)
5.2.1 Global Pirfenidone Tablets Revenue by Application (2021–2026)
5.2.2 Global Pirfenidone Tablets Revenue by Application (2027–2032)
5.2.3 Global Pirfenidone Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Pirfenidone Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Pirfenidone Tablets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Accord Healthcare Pirfenidone Tablets Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Company Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Amneal Pharmaceuticals Pirfenidone Tablets Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex Pirfenidone Tablets Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Company Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sandoz Pirfenidone Tablets Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Pirfenidone Tablets Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 ScieGen Pharmaceuticals
6.7.1 ScieGen Pharmaceuticals Company Information
6.7.2 ScieGen Pharmaceuticals Description and Business Overview
6.7.3 ScieGen Pharmaceuticals Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ScieGen Pharmaceuticals Pirfenidone Tablets Product Portfolio
6.7.5 ScieGen Pharmaceuticals Recent Developments/Updates
6.8 Kawin
6.8.1 Kawin Company Information
6.8.2 Kawin Description and Business Overview
6.8.3 Kawin Pirfenidone Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Kawin Pirfenidone Tablets Product Portfolio
6.8.5 Kawin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Tablets Industry Chain Analysis
7.2 Pirfenidone Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Tablets Production Mode & Process Analysis
7.4 Pirfenidone Tablets Sales and Marketing
7.4.1 Pirfenidone Tablets Sales Channels
7.4.2 Pirfenidone Tablets Distributors
7.5 Pirfenidone Tablets Customer Analysis
8 Pirfenidone Tablets Market Dynamics
8.1 Pirfenidone Tablets Industry Trends
8.2 Pirfenidone Tablets Market Drivers
8.3 Pirfenidone Tablets Market Challenges
8.4 Pirfenidone Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pirfenidone Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pirfenidone Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pirfenidone Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pirfenidone Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pirfenidone Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pirfenidone Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pirfenidone Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pirfenidone Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pirfenidone Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pirfenidone Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pirfenidone Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Pirfenidone Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pirfenidone Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pirfenidone Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pirfenidone Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pirfenidone Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Pirfenidone Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Pirfenidone Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Pirfenidone Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Pirfenidone Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pirfenidone Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Pirfenidone Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pirfenidone Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pirfenidone Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pirfenidone Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pirfenidone Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pirfenidone Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pirfenidone Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pirfenidone Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Pirfenidone Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Pirfenidone Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Pirfenidone Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Pirfenidone Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pirfenidone Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pirfenidone Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Pirfenidone Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Pirfenidone Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pirfenidone Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pirfenidone Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Pirfenidone Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Pirfenidone Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Pirfenidone Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Pirfenidone Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pirfenidone Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pirfenidone Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Pirfenidone Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Pirfenidone Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pirfenidone Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Pirfenidone Tablets Product
Table 74. Roche Recent Developments/Updates
Table 75. Accord Healthcare Company Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Accord Healthcare Pirfenidone Tablets Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Amneal Pharmaceuticals Company Information
Table 81. Amneal Pharmaceuticals Description and Business Overview
Table 82. Amneal Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Amneal Pharmaceuticals Pirfenidone Tablets Product
Table 84. Amneal Pharmaceuticals Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Apotex Pirfenidone Tablets Product
Table 89. Apotex Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sandoz Pirfenidone Tablets Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Pirfenidone Tablets Product
Table 99. Teva Recent Developments/Updates
Table 100. ScieGen Pharmaceuticals Company Information
Table 101. ScieGen Pharmaceuticals Description and Business Overview
Table 102. ScieGen Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. ScieGen Pharmaceuticals Pirfenidone Tablets Product
Table 104. ScieGen Pharmaceuticals Recent Developments/Updates
Table 105. Kawin Company Information
Table 106. Kawin Description and Business Overview
Table 107. Kawin Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Kawin Pirfenidone Tablets Product
Table 109. Kawin Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Pirfenidone Tablets Distributors List
Table 113. Pirfenidone Tablets Customers List
Table 114. Pirfenidone Tablets Market Trends
Table 115. Pirfenidone Tablets Market Drivers
Table 116. Pirfenidone Tablets Market Challenges
Table 117. Pirfenidone Tablets Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pirfenidone Tablets
Figure 2. Global Pirfenidone Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pirfenidone Tablets Market Share by Type: 2025 & 2032
Figure 4. 200mg per Tablet Product Picture
Figure 5. 267mg per Tablet Product Picture
Figure 6. 801mg per Tablet Product Picture
Figure 7. Global Pirfenidone Tablets Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Pirfenidone Tablets Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Pirfenidone Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Pirfenidone Tablets Market Size (US$ Million), 2021–2032
Figure 14. Global Pirfenidone Tablets Sales (K Units), 2021–2032
Figure 15. Global Pirfenidone Tablets Average Price (US$/Unit), 2021–2032
Figure 16. Pirfenidone Tablets Report Years Considered
Figure 17. Pirfenidone Tablets Sales Share by Manufacturers in 2025
Figure 18. Global Pirfenidone Tablets Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Pirfenidone Tablets Players: Market Share by Revenue in Pirfenidone Tablets in 2025
Figure 20. Pirfenidone Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Pirfenidone Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 23. North America Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 24. United States Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 27. Europe Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 28. Germany Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Pirfenidone Tablets Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Pirfenidone Tablets Revenue Market Share by Region (2021–2032)
Figure 35. China Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 43. Latin America Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Pirfenidone Tablets by Type (2021–2032)
Figure 54. Global Revenue Market Share of Pirfenidone Tablets by Type (2021–2032)
Figure 55. Global Pirfenidone Tablets Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Pirfenidone Tablets by Application (2021–2032)
Figure 57. Global Revenue Market Share of Pirfenidone Tablets by Application (2021–2032)
Figure 58. Global Pirfenidone Tablets Price (US$/Unit) by Application (2021–2032)
Figure 59. Pirfenidone Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Pirfenidone Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pirfenidone Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pirfenidone Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pirfenidone Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Pirfenidone Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pirfenidone Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pirfenidone Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pirfenidone Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pirfenidone Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pirfenidone Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pirfenidone Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Pirfenidone Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pirfenidone Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pirfenidone Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pirfenidone Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pirfenidone Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Pirfenidone Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Pirfenidone Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Pirfenidone Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Pirfenidone Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pirfenidone Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Pirfenidone Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pirfenidone Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pirfenidone Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pirfenidone Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Pirfenidone Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Pirfenidone Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pirfenidone Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pirfenidone Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pirfenidone Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Pirfenidone Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Pirfenidone Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pirfenidone Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pirfenidone Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Pirfenidone Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Pirfenidone Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Pirfenidone Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Pirfenidone Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pirfenidone Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pirfenidone Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Pirfenidone Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Pirfenidone Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Pirfenidone Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Pirfenidone Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Pirfenidone Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Pirfenidone Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Pirfenidone Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Pirfenidone Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pirfenidone Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pirfenidone Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Pirfenidone Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Pirfenidone Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Pirfenidone Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Pirfenidone Tablets Product
Table 74. Roche Recent Developments/Updates
Table 75. Accord Healthcare Company Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Accord Healthcare Pirfenidone Tablets Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Amneal Pharmaceuticals Company Information
Table 81. Amneal Pharmaceuticals Description and Business Overview
Table 82. Amneal Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Amneal Pharmaceuticals Pirfenidone Tablets Product
Table 84. Amneal Pharmaceuticals Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Apotex Pirfenidone Tablets Product
Table 89. Apotex Recent Developments/Updates
Table 90. Sandoz Company Information
Table 91. Sandoz Description and Business Overview
Table 92. Sandoz Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sandoz Pirfenidone Tablets Product
Table 94. Sandoz Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Pirfenidone Tablets Product
Table 99. Teva Recent Developments/Updates
Table 100. ScieGen Pharmaceuticals Company Information
Table 101. ScieGen Pharmaceuticals Description and Business Overview
Table 102. ScieGen Pharmaceuticals Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. ScieGen Pharmaceuticals Pirfenidone Tablets Product
Table 104. ScieGen Pharmaceuticals Recent Developments/Updates
Table 105. Kawin Company Information
Table 106. Kawin Description and Business Overview
Table 107. Kawin Pirfenidone Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Kawin Pirfenidone Tablets Product
Table 109. Kawin Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Pirfenidone Tablets Distributors List
Table 113. Pirfenidone Tablets Customers List
Table 114. Pirfenidone Tablets Market Trends
Table 115. Pirfenidone Tablets Market Drivers
Table 116. Pirfenidone Tablets Market Challenges
Table 117. Pirfenidone Tablets Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pirfenidone Tablets
Figure 2. Global Pirfenidone Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pirfenidone Tablets Market Share by Type: 2025 & 2032
Figure 4. 200mg per Tablet Product Picture
Figure 5. 267mg per Tablet Product Picture
Figure 6. 801mg per Tablet Product Picture
Figure 7. Global Pirfenidone Tablets Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Pirfenidone Tablets Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Pirfenidone Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Pirfenidone Tablets Market Size (US$ Million), 2021–2032
Figure 14. Global Pirfenidone Tablets Sales (K Units), 2021–2032
Figure 15. Global Pirfenidone Tablets Average Price (US$/Unit), 2021–2032
Figure 16. Pirfenidone Tablets Report Years Considered
Figure 17. Pirfenidone Tablets Sales Share by Manufacturers in 2025
Figure 18. Global Pirfenidone Tablets Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Pirfenidone Tablets Players: Market Share by Revenue in Pirfenidone Tablets in 2025
Figure 20. Pirfenidone Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Pirfenidone Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 23. North America Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 24. United States Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 27. Europe Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 28. Germany Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Pirfenidone Tablets Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Pirfenidone Tablets Revenue Market Share by Region (2021–2032)
Figure 35. China Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 43. Latin America Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Pirfenidone Tablets Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Pirfenidone Tablets Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Pirfenidone Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Pirfenidone Tablets by Type (2021–2032)
Figure 54. Global Revenue Market Share of Pirfenidone Tablets by Type (2021–2032)
Figure 55. Global Pirfenidone Tablets Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Pirfenidone Tablets by Application (2021–2032)
Figure 57. Global Revenue Market Share of Pirfenidone Tablets by Application (2021–2032)
Figure 58. Global Pirfenidone Tablets Price (US$/Unit) by Application (2021–2032)
Figure 59. Pirfenidone Tablets Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232